The stock of Opko Health Inc (NASDAQ:OPK) last traded at $1.34, down -0.74% from the previous session.
OPK stock price is now -2.57% away from the 50-day moving average and -12.55% away from the 200-day moving average. The market capitalization of the company currently stands at $1.06B.
On June 29, 2023, Barrington Research Upgraded its previous ‘Mkt Perform’ rating to ‘Outperform’ on the stock keeping its target price maintained at $2, while ‘H.C. Wainwright’ rates the stock as ‘Buy’
In other news, FROST PHILLIP MD ET AL, CEO & Chairman bought 125,000 shares of the company’s stock on Apr 10 ’25. The stock was bought for $169,712 at an average price of $1.36. Upon completion of the transaction, the CEO & Chairman now directly owns 214,001,448 shares in the company, valued at $286.76 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Apr 08 ’25, CEO & Chairman FROST PHILLIP MD ET AL bought 125,000 shares of the business’s stock. A total of $184,650 was incurred on buying the stock at an average price of $1.48. This leaves the insider owning 213,876,448 shares of the company worth $286.59 million. A total of 55.84% of the company’s stock is owned by insiders.
During the past 12 months, Opko Health Inc has had a low of $1.19 and a high of $2.04. As of last week, the company has a debt-to-equity ratio of 0.37, a current ratio of 2.49, and a quick ratio of 2.28.
The net profit margin was -5.66% and return on equity was -3.04% for OPK.
